Phase II study of UFT® plus leucovorin in colorectal cancer

Oncology (Switzerland)

Volumn 54, Issue , 1997, Pages 19-23

  Pazdur, Richard ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

5 Fluorouracil; Colorectal Cancer; UFT

Indexed keywords

FLUOROURACIL; FOLINIC ACID; TEGAFUR; UFT; URACIL;

ABDOMINAL CRAMP; ANOREXIA; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; DIARRHEA; FATIGUE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COLORECTAL NEOPLASMS; DRUG COMBINATIONS; HUMANS; LEUCOVORIN; NEOPLASM METASTASIS; SURVIVAL ANALYSIS; TEGAFUR; URACIL;

EID: 0031060206     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227741     Document Type: Article

References (18)

1. Friedman MA, Ifnoflfo RJ: A review of the United States clinical experience of the fluoro-pyridimine Ftorafur (NSC-148958). Cancer Treat Rev 1980;7:205-213.
2. Buroker T, Padilla F, Groppc C, Guy G, et al: Phase II evaluation of Ftorafur in previously untreated colorectal cancer, a Southwest Oncology Group study. Cancer 1979;44:48-51.
3. Valdivieso M, Godey GP, Gottlieb JA, et al: Clinical evaluation of Ftorafur. Cancer Res 1976;36:1821-1824.
4. Ansfield FJ, Kallas GJ, Singson JP: Phase I-II studies of oral Tcgafur (Ftorafur). J Clin Oncol 1983;1:107-110.
5. Ikenaka K, Shirasaka T, Kitano S: Effect of Uracil on metabolism of 5-fluorouracil in vitro. Gann 1979;70:353-359.
6. Fujii S, Ikenaka M, Fukushima M, et al: Effect of coadministration of Uracil or cytosine on the antitumor activity of l-(2-tetrahydro-furyl)-5-fluorouracil and level of 5-fluorouracil in rodents. Gann 1979:70:209-214.
7. Pazdur R, Ho DH, Lassere Y, Brcady B, Krakoff IH, Raber MN: Phase I trial of oral ftorafur (FT) and Uracil (abstract). Proc Am Soc Clin Oncol 1992,11:111.
8. Jaiycsimi I, Pazdur R, Ho DH, Lassere Y, Moore D, Brcady B, et al: Phase I trial of UFT (ftorafur plus Uracil) and leucovorin (abstract). Proc Am Soc Clin Oncol 1993; 12:152.
9. Pazdar R, Diaz-Canton E, Lassere Y, Bready B, Winn R, Ajani JA: Phase I trial of UFT (UracikTegafur) with leucovorin: 14-day schedule (abstract). Proc Am Soc Clin Oncol 1995:14:482.
10. Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV, et al: Phase II trial of UFT plus oral leucovorin: An effective oral treatment regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 1994; 12:2296-2300.
11. Pazdur R, Rhodes V, Lassere Y, Brcady B, Soo E, Ajani JA, et al: UFT plus leucovorin: A potentially effective oral regimen in colorectal carcinoma (abstract). Proc Am Soc Clin Oncol 1994:13:201.
12. Buroker TR, O’Connell MJ, Wicand HS, Krook JE, Gerstner JB, Mailliard JA, et al: Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal carcinoma. J Clin Oncol 1994;12:14-20.
13. Petrelli N, Douglass HO Jr., Herrera L, et al: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 1989;7:1419-1426.
14. Leiehman CG, Fleming TR, Muggia FM. et al: Fluorouracil schedules and modulation in advanced colorectal cancer. A Southwest Oncology Group screening trial (abstract). Proc Am Soc Clin Oncol 1993;12:198.
15. Saltz LB, Leiehman CG, Leichman LL, Young CW, Muggia FM, Conti JA, et al: A fixed ratio combination of Uracil and ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer. Cancer 1995;75: 782-785.
16. González Barón M, Feliu J, de la Gandara I, Espinosa E, Colmenarejo A, Martinez-Marti-nez B, et al: Efficacy of oral Tegafur modulation by Uracil and leucovorin in advanced colorectal cancer. A phase II study. Eur J Cancer 1995;31A:2215-2221.
17. Ho DH, Covington W, Pazdur R, Brown N, Kuritani J, Newman RA, et al: Clinical pharmacology of combined oral Uracil and ftorafur. DrugMetab Dispos 1992;20:936-940.
18. Pazdur R, Ho DH, Covington WP, Brown NS, Lassere Y, Diaz-Canton E: Comparative steady state pharmacokinetics of oral UFT versus protracted intravenous 5-fluorouracil (abstract). Proc Am Soc Clin Oncol 1996; 15:478.